RSS   Newsletter   Contact   Advertise with us
Post Online Media
Post Online Media Magazine

Neos Therapeutics appoints James Robinson to board

Share on Twitter Share on LinkedIn
Staff Writer | Grand Prairie, Tx., USA |
James RobinsonNeos Therapeutics, an oral drug delivery company, announced the appointment of James Robinson to its board of directors.
Mr. Robinson currently serves as the President and Chief Operating Officer of Alkermes plc.

Mr. Robinson currently serves as the President and Chief Operating Officer of Alkermes, where he leads the commercial, operations, business development, and human resources functions.

Prior to joining Alkermes, Mr. Robinson joined Astellas in 2005 as vice president of health systems, rising to President of Astellas Americas Operations in 2016.

Prior to joining Astellas, he served as an executive at the former Schering-Plough Corporation, which was acquired by Merck & Company in 2009.

Mr. Robinson is a member of The Commercial Club of Chicago and serves on the BioScience Council for ChicagoNEXT.

He is a founding member of MATTER and is also on the Board of Directors for the Chicago Botanic Garden.

Mr. Robinson received his Bachelor of Science degree from DePaul University.


 LATEST MOVES FROM Texas 


POST Online Media Contact